Neuroendocrine Tumor clinical trials
17 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
- CapTemY90 for Grade 2/3 NET Liver Metastases
- Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
- Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- Natural History of Familial Carcinoid Tumor
- Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
- An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
- Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)
- Evaluation of Study Experiences of Neuroendocrine Tumor Patients
- RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Neuroendocrine Tumor” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.